Concepedia

Roberta Fazi

RF

Statistics

Publications

6

Citations

308

H-Index

6

Active since

2004

Affiliations

University of Siena(Current)

Temple University

Istituto di Genetica Molecolare

Siena Biotech (Italy)

University of Florence

Roberta Fazi is an author at University of Siena specializing in viral helicase inhibitors, rna helicase activity, and infectious diseases.

Publications per year

2004–2020

6

Publications

6

Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents

Annalaura Brai, Roberta Fazi, Cristina Tintori et al. · Proceedings of the National Academy of Sciences · 2016 · 112 citations · Full text

, , +16

Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors

Roberta Fazi, Cristina Tintori, Annalaura Brai et al. · Journal of Chemical Information and Modeling · 2015 · 101 citations

, , +17

DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection

Annalaura Brai, Francesco Martelli, Valentina Riva et al. · Journal of Medicinal Chemistry · 2019 · 58 citations · Full text

, , +17

Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses

Valentina Riva, Anna Garbelli, Annalaura Brai et al. · Journal of Medicinal Chemistry · 2020 · 14 citations · Full text

, , +17

2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors

Marika Tiberi, Cristina Tintori, Elisa Rita Ceresola et al. · Antimicrobial Agents and Chemotherapy · 2014 · 13 citations · Full text

, , +17

1–5 of 6